Objective: Health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc), a chronic disabling dis- ease associated to physical and psychological impairment, is often left behind in clinical practice and research. This is due to the use of tools that are not complete or mainly designed for the physical condition only. We tested EQ-5D, a valid, simple and brief questionnaire for HRQoL that has never been validated in SSc. Methods: 33 consecutive SSc patients referring to our Rheumatology Department and undergoing treatment have been asked to fulfil EQ-5D together with HAQ. Results: EQ-5D demonstrated good acceptability, feasibility and validity in patients affected by SSc. Conceptually equiv- alent domains of EQ-5D demonstrated a good correlation with HAQ correspondent domains. Conclusions: We suggest the use of EQ-5D in SSc patients as a HRQoL measure in clinical practice, as well as an out- come parameter in randomized clinical trials and/or in pharmaco-economic evaluations.
La valutazione della qualità della vita nei pazienti con sclerodermia = Health related quality of life assessment in patients with systemic sclerosis / R. Gualtierotti, L. Scalone, F. Ingegnoli, P. Cortesi, C. Lubatti, S. Zeni, P. Meroni. - In: REUMATISMO. - ISSN 0048-7449. - 62:3(2010), pp. 210-214. (Intervento presentato al 46. convegno Congresso Nazionale della Societa' italiana di reumatologia (Sir). tenutosi a Rimini nel 2009) [10.4081/reumatismo.2010.210].
La valutazione della qualità della vita nei pazienti con sclerodermia = Health related quality of life assessment in patients with systemic sclerosis
R. GualtierottiPrimo
;F. Ingegnoli;
2010
Abstract
Objective: Health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc), a chronic disabling dis- ease associated to physical and psychological impairment, is often left behind in clinical practice and research. This is due to the use of tools that are not complete or mainly designed for the physical condition only. We tested EQ-5D, a valid, simple and brief questionnaire for HRQoL that has never been validated in SSc. Methods: 33 consecutive SSc patients referring to our Rheumatology Department and undergoing treatment have been asked to fulfil EQ-5D together with HAQ. Results: EQ-5D demonstrated good acceptability, feasibility and validity in patients affected by SSc. Conceptually equiv- alent domains of EQ-5D demonstrated a good correlation with HAQ correspondent domains. Conclusions: We suggest the use of EQ-5D in SSc patients as a HRQoL measure in clinical practice, as well as an out- come parameter in randomized clinical trials and/or in pharmaco-economic evaluations.File | Dimensione | Formato | |
---|---|---|---|
mikimos,+Lavoro+04-+Gualtierotti-210-214.pdf
accesso aperto
Descrizione: Article
Tipologia:
Publisher's version/PDF
Dimensione
60.44 kB
Formato
Adobe PDF
|
60.44 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.